Noxopharm Ltd has released a press release.
NOX researching rare Abscopal Response
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- Brain Cancer Study Commences
- First NOX66 Clinical Trial to Commence
- Breakthrough in Delivering Idronoxil into Brain
- Initial Clinic Study Announced and Approved
- Amendment to Preliminary Final Report
Later from Noxopharm
- Noxopharm and UNSW combine on stroke project
- NOX and Monash Uni Collaboration Receives Federal Grant
- NOX Files Patent Application on Smart Idronoxil
- Market Guidance for Next Six Months
- NOX makes strategic commitment to treatment of rare cancers
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm